News & Updates

Multiparametric ultrasound helps detect clinically significant prostate cancers, although magnetic resonance imaging (MRI) scans are slightly better, as reported in a study.

Patients with prostate cancer (PCa) have lower levels of melatonin than those without PCa, independent of urinary symptomatology or extension and aggressiveness of the tumour, a study has found.

In children with cancer, early diagnosis and proper and timely treatment of ecthyma gangrenosum (EG) are necessary to achieve recovery and to prevent larger necrotic lesions, which eventually evolve in scarring sequelae, suggests a study.

In patients with metastatic castration-resistant prostate cancer (mCRPC) who experience disease progression while on enzalutamide treatment, continuing enzalutamide appears to improve progression-free survival (PFS), according to results of the phase IIIb PRESIDE trial.